Fibristal voluntarily withdrawn in Canada due to risk of serious liver injuryAllergan withdraws and recalls uterine fibroid drug ulipristal acetate in Canada due to rare cases of severe liver injury requiring liver transplantation Under-diagnosed and under-treated: Supporting patients with chronic venous disease Counselling Corner: Educate your patients about the importance of using chambers with inhalers A conversation with PANS president Dr. Curtis Chafe Pharmacist leads therapeutic nutrition program for disease management Virtual conference on October 3 to focus on the implications of therapeutic nutrition on Type 2 diabetes. Survey finds doctors worry supplies of flu vaccine, PPE will lag demand Three quarters of those asked believe the healthcare system is better prepared with COVID-19 resurgences than during the first wave Ontario opioid related overdose deaths rose 34% in 2019 USask program trains techs to address substance use New e-portal to report loss/theft of controlled substances FDA finalizes rule for Canadian drug importation First Previous 395 396 397 398 399 Next Last
